https://www.nzdoctor.co.nz/everybody-patient-sheets

General Practice

Gordon Royle pradaxa
+Clinical

New Zealand contributes to trial success for dabigatran reversal

New Zealanders made up about a third of participants when idarucizumab was trialled internationally for reversing anti-coagulation

Read more
By Virginia McMillan
Friday 18 August 2017, 05:21 PM
0
Back to The newspaper

Article archive

Latest news

Fifty-year-old migraine treatment to be phased out

21/11/2019
0

Kaeo community between a WOCC and a hard place

21/11/2019
0

Medical school boss hits out at holidaying students’ ‘sense of entitlement’

20/11/2019
1

DHB under fire for proposal to scrap primary care role

20/11/2019
4

Positive publicity about HCH journey sees practice swamped

20/11/2019
0

Medical Council to rule on fitness of holidays-for-internship students before they can start work

19/11/2019
1

Australian GPs ‘among the world’s happiest’

19/11/2019
4

Two couples now on board at Junction Health

19/11/2019
0

Wairoa to be one-practice town as DHB closes primary care clinic

19/11/2019
1

Baby born with brain damage after ‘seriously suboptimal’ care

18/11/2019
1

Fewer hospital biopsies a signpost on Southern road to Planned Care

18/11/2019
0

NZMA fights on, college hopes ministry will listen, as euthanasia bill heads to referendum

15/11/2019
0

Monday Memo: 18 November 2019

18/11/2019
0

Latest issue

NZD Cover 20112019

20 November 2019

View all issues

Facebook

New Zealand Doctor

Twitter